Effects of SB 217242, a non-selective endothelin (ET)-A and ET-B receptor antagonist, in healthy humans.

被引：0
|
作者：
Freed, MI
Thompson, KA
Wilson, DE
Ohlstein, EH
Dennis, M
Jorkasky, DK
机构：
[1] SMITHKLINE BEECHAM PHARMACEUT, DEPT CLIN PHARMACOL, PHILADELPHIA, PA USA
[2] SMITHKLINE BEECHAM PHARMACEUT, DEPT CARDIOVASC PHARMACOL, PHILADELPHIA, PA USA
[3] SMITHKLINE BEECHAM PHARMACEUT, DEPT DRUG METAB & PHARMACOKINET, PHILADELPHIA, PA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A1558 / A1558
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF THE ET(A)/ET(B) RECEPTOR ANTAGONIST, BOSENTAN ON ENDOTHELIN-1-INDUCED MYOCARDIAL-ISCHEMIA AND EDEMA IN THE RAT
    FILEP, JG
    FOURNIER, A
    FOLDESFILEP, E
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (02) : 1745 - 1750
  • [22] Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure
    Leslie, SJ
    Spratt, JCS
    McKee, SP
    Strachan, FE
    Newby, DE
    Northridge, DB
    Denvir, MA
    Webb, DJ
    HEART, 2005, 91 (07) : 914 - 919
  • [23] COMPARISON WITH ET-A AND ET-B RECEPTOR-MEDIATED CARDIORENAL AND ENDOCRINE FUNCTIONS OF ENDOGENOUS ENDOTHELIN IN CONGESTIVE-HEART-FAILURE
    WADA, A
    MAEDA, Y
    TSUTAMOTO, T
    MATSUDA, Y
    KINOSHITA, M
    CIRCULATION, 1994, 90 (04) : 173 - 173
  • [24] Comparison of the ETA receptor potency of selective and non-selective ET antagonists in vivo and in vitro
    Flynn, DA
    Birrell, MA
    Brazdil, R
    McCormick, J
    Layland, K
    Brown, TJ
    Roach, AG
    Sargent, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P221 - P221
  • [25] Mutational analysis of the endothelin type A receptor (ET(A)): Interactions and model of the selective ET(A) antagonist EMS-182874 with the putative ET(A) receptor binding cavity
    Webb, ML
    Patel, PS
    Rose, PM
    Liu, ECK
    Stein, PD
    Barrish, J
    Lach, DA
    Stouch, T
    Fisher, SM
    Hadjilambris, O
    Lee, H
    Skwish, S
    Dickinson, EKJ
    Krystek, SR
    BIOCHEMISTRY, 1996, 35 (08) : 2548 - 2556
  • [26] RES-701-1: A novel endothelin ET(B) receptor antagonist
    Karaki, H
    Matsuda, Y
    CARDIOVASCULAR DRUG REVIEWS, 1996, 14 (01): : 17 - 35
  • [27] A non-selective endothelin receptor antagonist CPU0213 suppresses the ET-ROS axis to improve acute heart failure in septic shock rats
    He, HB
    Dai, DZ
    Ji, M
    DRUG DEVELOPMENT RESEARCH, 2005, 66 (03) : 224 - 225
  • [28] TRUNCATED ANALOGS OF ENDOTHELIN AND SARAFOTOXIN ARE SELECTIVE FOR THE ET(B) RECEPTOR SUBTYPE
    HEYL, DL
    CODY, WL
    HE, JX
    FLYNN, MA
    WELCH, KM
    REYNOLDS, EE
    DOHERTY, AM
    PEPTIDE RESEARCH, 1993, 6 (05): : 238 - 241
  • [29] Effects of endothelin (ET) receptor selective and non-selective antagonists on ET-1-inhibited L-type Ca2+ currents in ventricular cardiomyocytes isolated from rabbit myocardium
    Kelso, EJ
    Spiers, JP
    McDermott, BJ
    Scholfield, CN
    Silke, B
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 : P56 - P56
  • [30] Bosentan, a novel endothelin ET(A)/ET(B) receptor antagonist, inhibits vasoconstrictor responses to angiotensin in the cat.
    McWilliams, SM
    Champion, HC
    Lambert, DG
    Czapla, MA
    Davis, SS
    Mikesh, CS
    Filep, JG
    Kadowitz, PJ
    FASEB JOURNAL, 1997, 11 (03): : 220 - 220
12345